SB66 SFA #1 Baldwin 2-14
Senator Baldwin moved to amend the bill by striking out everything after the enacting clause and inserting in lieu thereof the following:
ARTICLE 6N. PREVENTION OF DECEPTIVE ADVERTISING AND SOLICITATION PRACTICES.
§46A-6N-1. Short title.
This article shall be known and cited as the Prevention of Deceptive Advertising and Solicitation Practices Act.
§46A-6N-2. Deceptive advertising practices.
(a) Specifically prohibited advertising practices. — A person engages in a deceptive trade practice if in advertising legal services or pharmaceutical products the person does any of the following:
(1) Fails to disclose at the outset of the advertisement: “This is a paid advertisement for [“legal services” or “a pharmaceutical product”]”;
(2) Presents an advertisement as a “medical alert”, “health alert”, “consumer alert”, “public service announcement”, or similar phrase;
(3) Displays the logo of a federal or state government agency in a manner that suggests affiliation with the sponsorship of that agency;
(4) Uses the word “recall” when referring to a product that has not been recalled by a government agency or through an agreement between a manufacturer and a government agency;
(5) Fails to identify the sponsor of the advertisement; or
(6) Fails to indicate the identity of the attorney, law firm, manufacturer, or, in the case of legal services, how cases will be referred to attorneys or law firms that will represent clients if the sponsor of the advertisement will not represent persons responding to the advertisement.
(b) Disclosures and warnings for protection of patients. —
(1) An advertisement for legal services soliciting clients who may allege an injury from a prescription drug approved, cleared, or the subject of a monograph authorized by the United States Food and Drug Administration shall include the following warning: “Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death”.
(2) An advertisement for a lawsuit soliciting clients who may allege an injury from a prescription drug or medical device approved, cleared, or the subject of a monograph authorized by the United States Food and Drug Administration shall disclose that the drug or medical device remains approved by the United States Food and Drug Administration, unless the product has been recalled or withdrawn.
(3) An advertisement for a pharmaceutical product shall include:
(A) The trade/brand name or proprietary name, if any, including name(s) of the active ingredient(s);
(B) The major indication(s) for use;
(C) The major precautions, contra-indications and warnings; and
(D) The average retail price.
(c) Appearance of required statements, disclosures, and warnings. — Any words or statements required by this section to appear in an advertisement must be presented clearly and conspicuously.
(1) Written disclosures shall be clearly legible and, if televised or displayed electronically, shall be displayed for a sufficient time to enable the viewer to easily see and fully read the disclosure or disclaimer.
(2) Spoken disclosures shall be plainly audible and clearly intelligible.
(d) Definitions. — For purposes of this section:
(1) “Legal advertisement” means a solicitation for legal services through television, radio, internet (including a domain name), newspaper, or other periodical, outdoor display, or other written, electronic, or recorded communications.
(2) “Person” includes any person, entity, attorney, or law firm that advertises legal services or identifies potential clients for attorneys or law firms.
§46A-6N-3. Wrongful use or disclosure of protected health information for solicitation of legal services.
(a) Use or disclosure of protected health information for legal solicitation. — A person shall not use, cause to be used, obtain, sell, transfer, or disclose to another person without written authorization protected health information for the purposes of soliciting an individual for legal services or pharmaceutical products.
(b) Definitions. — For purposes of this section:
(1) “Person” includes an attorney, law firm, manufacturer, or individual entity that solicits individuals for legal services, pharmaceutical products or identifies potential clients for attorneys or law firms.
(2) “Protected health information” has the meaning given to the term in section 160.103 of title 45, Code of Federal Regulations.
(3) “Solicit” means offer to provide legal services or pharmaceutical products by written, recorded, or electronic communication, or by in-person, telephone, or real-time electronic contact.
(c) Enforcement. —
(1) A violation of this section constitutes a violation of West Virginia’s health privacy laws or §46A-6-101 et seq. of this code.
(2) In addition to any other remedy provided by law, a person who willfully and knowingly violates this section shall be guilty of a misdemeanor and, upon conviction thereof, be confined in jail not more than one year, be fined $1,000, or both.
(d) Construction. — This provision may not be construed to apply to the use or disclosure of protected health information to an individual’s legal representative, in the course of any judicial or administrative proceeding, or as otherwise permitted or required by law.
§46A-6N-4. Authority of judiciary or State Bar to regulate practice of law.
Nothing in this act shall limit or otherwise affect the authority of the judiciary or the Lawyer Disciplinary Board to regulate the practice of law, enforce the West Virginia Rules of Professional Conduct, or discipline persons admitted to the bar.